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The Transcriptional Coactivator DRIP/Mediator
Complex Is Involved in Vitamin D Receptor Function and
Regulates Keratinocyte Proliferation and Differentiation
Yuko Oda1, Robert J. Chalkley2, Alma L. Burlingame2 and Daniel D. Bikle1
Mediator is a multisubunit coactivator complex that facilitates transcription of nuclear receptors. We
investigated the role of the mediator complex as a coactivator for vitamin D receptor (VDR) in keratinocytes.
Using VDR affinity beads, the vitamin D receptor interacting protein (DRIP)/mediator complex was purified from
primary keratinocytes, and its subunit composition was determined by mass spectrometry. The complex
included core subunits, such as DRIP205/MED1 (MED1), that directly binds to VDR. Additional subunits were
identified that are components of the RNA polymerase II complex. The functions of different mediator
components were investigated by silencing its subunits. The core subunit MED1 facilitates VDR activity and
regulating keratinocyte proliferation and differentiation. A newly described subunit MED21 also has a role in
promoting keratinocyte proliferation and differentiation, whereas MED10 has an inhibitory role. Blocking
MED1/MED21 expression caused hyperproliferation of keratinocytes, accompanied by increases in mRNA
expression of the cell cycle regulator cyclin D1 and/or glioma-associated oncogene homolog. Blocking MED1
or MED21 expression also resulted in defects in calcium-induced keratinocyte differentiation, as indicated by
decreased expression of differentiation markers and decreased translocation of E-cadherin to the membrane.
These results show that keratinocytes use the transcriptional coactivator mediator to regulate VDR functions
and control keratinocyte proliferation and differentiation.
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INTRODUCTION
The active metabolite of vitamin D, 1,25-dihydroxyvitamin
D (1,25(OH)2D3), regulates transcription through its binding
to the vitamin D receptor (VDR) for subsequent regulation
of proliferation and differentiation in a number of cells,
including keratinocytes (Bikle, 1996; Haussler et al., 1998).
The VDR binds selectively to genomic sites, termed VDR
response elements, and activate transcription (Haussler et al.,
1998). For example, binding of VDR to 1,25(OH)2D3 induces
transcription of 24 hydroxylase (24OHase) through VDR
response element sequences in its promoter (Haussler et al.,
1998). The expression of the antimicrobial cathelicidin
(CAMP) is likewise regulated by 1,25(OH)2D3 and VDR to
facilitate the innate immune response in the skin (Schauber
et al., 2008). VDR also interacts with Wnt/catenin signaling
(Palmer et al., 2001). VDR binds to b-catenin (Shah et al.,
2006), modulating the impact of b-catenin on proliferation and
differentiation of keratinocytes (Palmer et al., 2008). Several
Wnt target genes, which are upregulated in the skin of the
activated b-catenin mouse model, including cell cycle
regulator cyclin D1, oncogene glioma-associated oncogene
homolog (Gli 1; transcription factor and target gene in the
Hedgehog pathway), peptidyl arginine deiminase 1 (PADI1),
are regulated by 1,25(OH)2D3 and VDR. These genes
possess VDR response elements similar to sequences in their
promoter, some of which may interact with TCF/Lef response
elements also found in the promoters of these genes
(Palmer et al., 2008). The 1,25(OH)2D3 independent actions
of VDR in keratinocytes have also been shown in in vivo
mouse models (Skorija et al., 2005). The most striking example
is alopecia, which is observed in VDR null mice, but not in
CYP27b1 (the enzyme producing 1,25(OH)2D3) null mice
(Bikle et al., 2004). However, similar 1,25(OH)2D3 indepen-
dent effects of VDR have been observed in in vitro keratino-
cyte culture systems (Ellison et al., 2007; Hawker et al., 2007).
These VDR actions are mediated by transcriptional
regulatory complexes called coactivators. We have
previously purified and identified the protein complex of
& 2010 The Society for Investigative Dermatology www.jidonline.org 2377
ORIGINAL ARTICLE
Received 18 November 2008; revised 17 March 2010; accepted 2 April 2010;
published online 3 June 2010
1Department of Medicine and Endocrinology, University of California,
San Francisco and Veterans Affairs Medical Center San Francisco, San
Francisco, California, USA and 2Department of Pharmaceutical Chemistry,
University of California, San Francisco, San Francisco, California, USA
Correspondence: Yuko Oda, Endocrine Research 111N, Department of
Medicine and Endocrinology, University of California,
San Francisco and Veterans Affairs Medical Center San Francisco, 4150
Clement Street, San Francisco, California 94121, USA.
E-mail: yuko.oda@ucsf.edu
Abbreviations: CAMP, cathelicidin; DRIP, vitamin D receptor interacting
protein; FLG, filaggrin; Gli 1, glioma-associated oncogene homolog;
LOR, loricrin; MS, mass spectrometry; 24OHase, 24 hydroxylase;
1,25(OH)2D3 or 1,25D3, 1,25-dihydroxyvitamin D3; PADI, peptidyl arginine
deiminase; RNA Pol, RNA polymerase; SCC, squamous carcinoma cells;
SRC, steroid receptor coactivator; VDR, vitamin D receptor
vitamin D receptor interacting proteins (DRIP) from primary
keratinocytes, as well as in the squamous carcinoma cell line
SCC12B2 (Oda et al., 2003) as VDR coactivators. Later, we
found out that DRIP complex belong to the transcriptional
coactivator complex called ‘‘Mediator’’ by structural simila-
rity. The mediator was first isolated as a complex binding to
thyroid hormone receptor (Ito et al., 2000; Ito and Roeder,
2001) and also is used by other nuclear receptors or
transcription factors (Ito et al., 2000; Ito and Roeder, 2001;
Bourbon et al., 2004) (Blazek et al., 2005; Kornberg, 2005).
This complex activates transcription by directly recruiting the
RNA polymerase (RNA Pol) II general transcriptional
machinery to the promoter of regulated genes.
The mediator is a multiprotein complex. One core subunit,
DRIP205/MED1 (referred to as MED1) that directly binds to
VDR and anchors the rest of the complex, is required for VDR
transactivation in keratinocytes (Oda et al., 2003). MED1 is
also involved in peroxisome proliferator activated receptor-
induced liver degeneration (Matsumoto et al., 2007) and
adipogenesis (Ge et al., 2002, 2008). However, the mediator
complex contains other subunits. A multidimensional study
using Hela cells showed 32 subunits in the mediator complex
(Sato et al., 2004). Structural analysis of yeast mediator
complex using electron microscopic studies proposed four
different modules referred to as kinase, head, middle, and tail
(Chadick and Asturias, 2005). The RNA Pol II binding to the
middle module causes a conformational change of the
mediator complex to activate transcription. Some subunits
were assigned to these modules but not all (Chadick and
Asturias, 2005). The mediator complex from primary
keratinocytes and SCC cells share core subunits such as
MED1 with mediator complexes in immortalized cells such
as Namalwa B or Hela cells. However, the presence of the
smaller molecular-weight subunits varies. The subunit
composition of the keratinocyte mediator complex also
differs from previously described mediator complexes thyroid
hormone receptor, Srb/Med containing cofactor complex, or
activator–recruited cofactor complex. These differences could
also emanate from technical differences in the analysis. On
the other hand, the mediator complex in immortalized cell
lines such as Hela cells may not represent the appropriate
regulatory complex critical for control of cell proliferation
and differentiation in normal cells because these cells are
characterized by their aberrant cell growth and lack of
differentiation. Therefore, we reexamined the mediator
complex from primary keratinocytes by tandem mass spectro-
metry (MS) to provide a more accurate identification of the
proteins involved.
We identified the core subunit MED1 along with
additional subunits not found in our earlier analysis of the
mediator complex. The functional relevance of these newly
described mediator subunits in VDR function and keratino-
cyte proliferation and differentiation was evaluated. Silencing
of the new subunit MED21 or the core subunit MED1 resulted
in significant morphological changes in epidermal keratino-
cytes and increased their proliferation. This was accompa-
nied by increased expression of cyclin D1 and/or Gli 1 and
loss of 1,25(OH)2D3 responsiveness. Silencing of MED21 and
MED1 also resulted in defects in keratinocyte differentiation,
accompanied by loss in formation of the E-cadherin–b-
catenin complex in the membrane. However, silencing of
MED10 inhibited proliferation and promoted 1,25(OH)2D3
responsiveness, showing differences in the roles of the
different subunits of mediator in VDR regulation of keratino-
cyte proliferation and differentiation.
RESULTS
In a previous study, we purified VDR binding protein
complexes from keratinocytes and determined their
identities mainly by matrix-assisted laser desorption/ioniza-
tion (MALDI) peptide mass mapping (Oda et al., 2003). Two
different coactivator complexes, mediator and steroid recep-
tor coactivator (SRC/p160), were identified at different stages
of differentiation. In this study, we examined the mediator
complex more comprehensively using tandem MS, which
produces sequence information and is more effective
for analyzing mixtures of proteins. Nuclear extracts
from proliferating human keratinocytes were incubated
with glutathione S-transferase (GST)-VDR ligand bind-
ing domain beads in the presence or absence of ligand
(1,25(OH)2D3). The bound proteins were eluted and sepa-
rated by SDS–PAGE. The multiple proteins, ranging in
molecular weight from 25 to 250 kDa, were then identified
by MS (Figure 1a and b). Specifically, the protein bands were
excised from the SDS gel and analyzed by liquid chromato-
graphy-electrospray ionization (nanoLC-ESI) tandem MS. The
protein identification results are presented in Table 1. The
core DRIP/Mediator subunits—DRIP250/MED13, DRIP240
/MED12, DRIP205/MED1, DRIP150/MED14, DRIP130/MED23,
DRIP100/MED24, DRIP92/MED16, DRIP77/MED17, and
DRIP33/MED6 were identified (nomenclature includes the
numbering scheme for the mediator complex as it relates to
the numbering scheme for the DRIP complex; Bourbon et al.,
2004). These proteins were previously observed in Namalwa
(Rachez et al., 1999) and SCC cells (Oda et al., 2003). MED1
is a critical subunit, as it directly binds to VDR and activates
VDR mediated transcription. Subunits MED10/hNut2,
MED21/hSrb7, and MED31/hSoh1 had previously not been
found in DRIP complexes from Namalwa and SCC cells (the
equivalent subunit name in yeast is shown with MED names;
Table 1). MED10 and 21 are reported to be components of
the RNA Pol II general complex. They may serve as adaptors
and convey regulatory information from promoter sites to the
general transcriptional machinery to activate or repress
transcription. The function of the core subunit MED1, as
well as these newly described components of the VDR
binding complex, was then explored.
The function of these mediator subunits in VDR activity
was examined using small interfering RNA (siRNA)-silencing
technology. Keratinocytes were transfected with siRNA for
VDR (siVDR), MED1 (siMED1), MED10 (siMED10), MED21
(siMED21), and MED31 (siMED31) to block their expression.
The effect of blockage on VDR transactivation was evaluated
by comparison to controls transfected with nontarget siRNA
(sicontrol). When VDR and MED1 were targeted by siRNA,
their mRNA expression (Supplementary Table S1 online)
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and protein levels (Figure 2a) were significantly reduced.
MED10, MED21, and MED31 silencing also led to significant
reductions in their mRNA levels (Supplementary Table S1
online). Protein levels of these subunits were not examined
because antibodies are not available. The VDR activity
was assessed by measuring 1,25(OH)2D3 induced 24OHase
and CAMP. Keratinocytes were treated with 1,25(OH)2D3,
and mRNA levels of 24OHase, CAMP, and control L19 were
measured using quantitative reverse transcriptase PCR
(QPCR). VDR silencing decreased VDR transactivation
(Figure 2c). When the major mediator subunit MED1 was
silenced, 1,25(OH)2D3 induced 24OHase expression signifi-
cantly decreased (Figure 2c), indicating a coactivator func-
tion for MED1, as expected. In contrast, when MED10 or
MED31 was silenced, 1,25(OH)2D3 induction of 24OHase
increased compared with control (Figure 2c), suggesting they
have a suppressive effect at least for the 24OHase. The same
negative function of MED10 was observed when a second
VDR target gene, CAMP, was examined. MED10 silencing
significantly increased both basal and 1,25(OH)2D3 induced
expression (Figure 2d). MED31 and MED21 silencing did not
show significant changes. These results indicate that the
mediator complex contains functionally distinct subunits.
We noticed that MED1, MED21, and VDR silencing
resulted in significant changes in morphology (from cuboidal
epithelia to spindle-shaped cells; Figure 3a, phase contrast).
To determine whether these morphological changes were
accompanied by changes in proliferation, we transfected the
cells with the siRNAs under low calcium (0.03mM) condi-
tions and examined proliferation, initially using the cell
proliferation assay (XTT). Significant increases in proliferation
were observed when MED1, MED21, or VDR were blocked
(data not shown). Proliferation was further evaluated using
the BrdU assay. BrdU incorporation was visualized histolo-
gically (Figure 3a BrdU staining), and the percentage of BrdU-
positive cells per total cells was determined (Figure 3b).
When VDR, MED1, or MED21 were blocked, the number of
BrdU-positive cells increased (Figure 3b). In contrast, MED10
silencing decreased proliferation shown by BrdU incorpora-
tion (Figure 3b). The changes in MED10 and MED21 were
statistically significant, although the effects were smaller
than those of silencing either MED1 or VDR. These
results suggested that MED1 and MED21 facilitate VDR
function in keratinocyte proliferation, but MED10 has an
inhibitory role.
To explore the mechanism by which silencing of MED1
and MED21 results in hyperproliferation, we investigated
their role on Wnt target genes that are also regulated by VDR.
Previously, it was reported that 1,25(OH)2D3 and VDR
regulate several Wnt target genes including cyclin D1, Gli
1, and PADI1 (Palmer et al., 2008). In this study we evaluated
MED1 and MED21 regulation of these genes in human
epidermal keratinocytes. We observed that 1,25(OH)2D3
repressed the expression of both cyclin D1 and Gli 1 in
human keratinocytes (Figure 4, sicontrol). When VDR was
blocked, the basal level of cyclin D1 increased (Figure 4)
despite the lack of 1,25(OH)2D3 in the medium suggesting
that VDR may have a ligand independent, as well as ligand
dependent ability to suppress cyclin D1 expression. The
1,25(OH)2D3 was still able to repress its expression, but to a
lesser extent compared with the control group, presumably,
as inhibition of VDR expression by siRNA was incomplete.
When MED1 or MED21 were blocked, a similar increase in
basal expression and decrease in repression by 1,25(OH)2D3
were observed (Figure 4) indicating their roles in the VDR
mediated suppression of cyclin D1. Gli 1 was regulated
similarly to cyclin D1 by VDR, MED1, and 1,25(OH)2D3
(Figure 4). In contrast to cyclin D1 and Gli 1, other Wnt target
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Figure 1. A purification of vitamin D receptor (VDR) binding proteins
from keratinocytes. Nuclear extracts from proliferating keratinocytes were
incubated with GST-VDR (LBD) affinity beads in the absence (a) and
presence (b) of ligand (1,25-dihydroxyvitamin D3). Bound proteins were
eluted, separated by SDS–PAGE, and visualized by silver staining. Apparent
molecular weights of these bands are shown. These protein bands were
excised from the SDS gel and analyzed by tandem mass spectrometry.
A ligand-independent binding protein without ligand (a) was not run
consecutively with (b) but consistently appeared as a single band (*) and
it was not analyzed. The model shows the mediator complex identified in
keratinocytes including core mediator subunits and the newly described
mediator subunits MED31, MED21, and MED10.
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Table 1. Protein identification of the VDR binding protein complex isolated from keratinocytes
Band Acc no. Num Pep Sequence coverage (%) Protein MW Protein name
p250 Q93074 28 12.8 247335.8 DRIP240/TRAP230/MED12
Q9UHV7 24 12.2 239233.5 DRIP250/TRAP240/MED13
p240 Q93074 66 33.5 247335.8 DRIP240/TRAP230/MED12
Q9UHV7 2 0.9 239233.5 DRIP250/TRAP240/MED13
p205 Q15648 55 34.5 168439.4 DRIP205/TRAP220/MED1
Q93074 2 1.0 247335.8 DRIP240/TRAP230/MED12
Q9UHV7 2 1.0 239233.5 DRIP250/TRAP240/MED13
p150 Q4KMR7 40 30.1 160608 DRIP150/TRAP170/MED14
Q93074 13 5.8 247335.8 DRIP240/TRAP230/MED12
Q15648 4 2.2 168439.4 DRIP205/TRAP220/MED1
p130 Q9ULK4 27 21.5 156475.5 DRIP130/MED23
Q4KMR7 23 16.3 160608 DRIP150/TRAP170/MED14
Q15648 4 2.1 168439.4 DRIP205/TRAP220/MED1
Q93074 2 0.9 247335.8 DRIP240/TRAP230/MED12
p100 O75448 15 18.4 110306.3 DRIP100/TRAP100/MED24
P92 Q9Y2X0 14 17.2 96794.1 DRIP92/TRAP95/MED16
O75448 11 11.7 110306.3 DRIP100/TRAP100/MED24
Q15648 2 1.1 168439.4 DRIP205/TRAP220/MED1
P77 Q9NVC6 15 24.1 72876.8 DRIP77/TRAP80/MED17
P11021 7 12.8 72333.5 GRP78/BiP
Q9UG63 2 3.7 71290.9 ATP-binding cassette subfamily
F member 2
P42 P23396 12 43.6 26688.6 40S ribosomal protein S3
P15880 8 22.5 31324.7 40S ribosomal protein S2
O75586 3 11.8 28424.9 DRIP33/MED6
P34 P23396 7 25.1 26688.6 40S ribosomal protein S3
P62701 7 18.3 29466.8 40S ribosomal protein S4
Q96G25 2 5.2 29080.2 MED8
P25 P62249 16 65.5 16314.3 40S ribosomal protein S16
P62269 10 44.7 17718.8 40S ribosomal protein S18
P62829 9 49.3 14865.6 60S ribosomal protein L23
P60866 5 35.5 13372.8 40S ribosomal protein S20
P62244 5 34.6 14708.5 40S ribosomal protein S15a
P39019 4 18.8 15929.4 40S ribosomal protein S19
Q5T8T9 3 18.6 16479.7 MED22/SURF5
Q9Y3C7 3 22.1 15805.3 MED31/hSOH1
P62263 2 14.0 16141.7 40S ribosomal protein S14
Q13503 2 17.4 15564.5 MED21/SURB7
Q9BTT4 2 16.3 15688.1 MED10/hNut2
P16402 2 9.5 22218.9 Histone H1 family member 2,
3, or 4
P07305 2 9.8 20731.9 Histone H1.0
P62807 2 12.8 13775.1 Histone H2B
Abbreviations: DRIP, vitamin D receptor interacting proteins; TRAP, thyroid hormone receptor.
Analysis of p25–p250 bands by tandem mass spectrometry is shown. Identifications are shown by NCBI accession number (Acc no.), number of peptides
identified (Num Pep), sequence coverage (%), calculated molecular weight (MW) of the protein, and protein name.
Nomenclature includes the numbering scheme for the mediator (bold letters).
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genes examined were found to be activated by 1,25(OH)2D3.
When VDR was blocked, 1,25(OH)2D3 induced transactiva-
tion of PADI1, which is involved in terminal differentiation,
was abolished. However, MED1 and MED21 silencing
did not change either basal or 1,25(OH)2D3 induced
transactivation (Figure 4), indicating that neither MED1 nor
MED21 is involved in its regulation. Our results suggest that
MED21 and MED1 may be involved in the VDR function
of repressing the Wnt target genes cyclin D1, but not in the
activation of PADI1.
Next we examined the effect of mediator subunits on
calcium-induced differentiation. Keratinocytes were trans-
fected with siRNA in low calcium media (0.03mM) for 2 days
to block the expression of VDR, MED1 (Figure 5a) and
the newly described subunits MED10, MED21, and
MED31 (Figure 5b). They were then switched to high
calcium (1.2mM) and maintained for 3 or 7 days to induce
differentiation. We have developed and verified a specific
method to extend efficacy of siRNA by using multiple
transfections of siRNA up to 7 days of culture. Blocking
efficiency stayed stable over time for at least 7 days as shown
in Supplementary Table S1 online and Figure 2b. Differentia-
tion was evaluated by measuring mRNA levels of various
differentiation markers. After 3 days of culture, levels of the
early markers keratin 1 and keratin 10 were increased (shown
by closed circles in inserts in the K1 and K10 graphs, Figure
5a and b). When MED1 (shown by squares in Figure 5a) or
MED21 (shown by squares in Figure 5b) were blocked, the
induction of K1 and K10 were significantly inhibited. MED10
and MED31 showed partial effects (Figure 5b inserts in K1
and K10 graphs). The expression of K1 and K10 further
increased by 7 days in control cells. Silencing of MED1
suppressed this induction (Figure 5a). MED10, 21, and 31
silencing had effects on K1, but not on K10 (Figure 5b 7 days).
In contrast, the mid-differentiation markers involucrin and
transglutaminase were less affected (Figure 5a and b). Late
differentiation markers, filaggrin (FLG) and loricrin (LOR),
were induced only after 7 days of culture not by 3 days.
When either MED1 (Figure 5a) or MED21 (Figure 5b) were
silenced, both FLG and LOR levels were dramatically
decreased, whereas silencing of MED10 and MED31 had
less (FLG) or no (LOR) effect (Figure 5b). These results suggest
that a new subunit MED21 and core subunit MED1 have a
critical role in keratinocyte differentiation, especially in early
and late differentiation, but less during midmarker formation.
Formation of the E-cadherin–b-catenin complex in the
membrane is a critical step in calcium-induced differentiation
(Xie and Bikle, 2007). To examine whether silencing VDR
and the MED subunits affects this process, the translocation of
E-cadherin and b-catenin to the membrane was examined.
Keratinocytes were transfected with the different siRNAs in
low calcium media (0.03mM) then switched to high calcium
(1.2mM). Immunofluorescence evaluation showed that kera-
tinocytes formed cell–cell contacts within 5minutes, and
E-cadherin and b-catenin colocalized to these regions, unlike
in cells in low calcium (Figure 6a, sicontrol). When VDR,
MED1, or MED21 were silenced, the translocation of both
E-cadherin and b-catenin to the membrane decreased
(Figure 6a, siVDR, siMED1, and siMED21). These results for
E-cadherin were confirmed by western analysis. Total and
plasma membrane lysates were prepared from keratinocytes
and translocation of E-cadherin to the membrane was
evaluated. Within 5minutes of high-calcium treatment,
E-cadherin levels increased in membrane fraction, although
the total levels of E-cadherin did not change (Figure 6b
sicontrol). When VDR, MED1, or MED21 were silenced,
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Figure 2. Mediator is involved in vitamin D receptor (VDR) transcriptional activities as shown by 24 hydroxylase expression. Keratinocytes were transfected
with small interfering RNA (siRNA) to block VDR or mediator subunit expression. Blocking efficiency of VDR (a, upper lanes) and MED1 proteins (a, lower lanes)
in keratinocytes transfected with sicontrol (lane 1), siVDR (lane 2), and siMED1 (lane 3) in 0.03mM calcium are shown (a). Blocking efficiency during
keratinocyte differentiation wherein cells are transfected with 0.03mM calcium and then switched to 1.2mM calcium and maintained for 3–7 days to induce
differentiation are also monitored (b), VDR expression in sicontrol 3 days (lane 4), siVDR 3 days (lane 5), siVDR 7 days (lane 6); and MED1 proteins in sicontrol
3 days (lane 7), siMED1 3 days (lane 8), siMED1 7 days (lane 9) are shown (these samples correspond to data shown in Figure 5a and b). Keratinocytes were then
treated with either vehicle (ethanol; open bars) or 1,25(OH)2D3 (closed bars) at 1 108 M (c, left graph and d) or 1 109 M (c, right graph). To normalize
the data in each experiment, the percentage of induction compared with sicontrol was calculated. Statistical significance evaluated by t-test (**Po0.01,
*Po0.05) compared with control is shown with asterisks. The results are representative of two separate experiments.
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the E-cadherin translocation was significantly inhibited
(Figure 6b siVDR, siMED1, and siMED21).
The calcium-sensing receptor (CaR) has a critical role in
mediating calcium-induced formation of the Ecadherin–b-
catenin complex (Tu et al., 2008), and is regulated by
1,25(OH)2D3 (Ratnam et al., 1999). Therefore, we examined
whether the loss of the ability of the keratinocyte to respond
to calcium associated with the regulation through CaR. The
mRNA levels of CaR decreased when VDR or MED1 is
silenced (Figure 6c left panel). Translocation of CaR to the
membrane was also affected. After high-calcium treatment,
CaR levels increased in the controls (Figure 6c, western blot
lanes 5, 6). When VDR or MED1 were silenced, both basal
and calcium-induced translocation decreased (Figure 6c,
western siVDR lanes 1, 2 and siMED1 lanes 3, 4). These
results indicate that blocking MED21, MED1, or VDR reduces
calcium-induced E-cadherin–b-catenin translocation to the
membrane, and this reduction may be associated with
decreased expression of CaR and/or its function in the
membrane.
DISCUSSION
In this study, we characterized the DRIP–Mediator complex
involved in VDR function in primary keratinocytes. Newly
described subunits of this complex were identified that were
not previously found in the mediator complexes of immorta-
lized keratinocytes SCC12B2 or Namalwa B cells (Rachez
et al., 1999; Oda et al., 2003). Normal keratinocytes may
therefore use a functionally distinct mediator assembly for
VDR regulation. The differences in function may be inferred
when these subunits are assigned to the module structures
proposed in yeast mediator (Blazek et al., 2005; Chadick and
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Figure 3. The blockage of mediator subunits resulted in hyperproliferation of keratinocytes. Keratinocytes were transfected with small interfering RNA (siRNA)
to block expression of vitamin D receptor (VDR) or mediator subunits. Silencing of VDR, MED1, MED21 resulted in morphological changes (a, phase
contrast). Bar ¼ 20mm. Proliferation was accessed by BrdU incorporation. BrdU was immunohistochemically visualized (a, BrdU staining; bars ¼ 20 mm), and
the ratio of BrdU-positive cells (brown) per total cells (blue nuclear counter staining) was calculated using Bioquant (Materials and Methods) (b). The data are
shown as mean± SD of three different preparations of keratinocytes. Statistical significance evaluated by t-test (**Po0.01, *Po0.05) compared with control is
shown with asterisks (b).
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Asturias, 2005). In this scheme, the middle module, which is
proposed to bind directly to RNA Pol II to activate or repress
transcription, is represented by the core subunit MED1.
The MED1 is essential for binding to VDR and activation of
transcription. Our data show that MED1 has a critical role in
VDR regulation of keratinocyte proliferation and differentia-
tion. Two other core components found in the yeast middle
module, DRIP34/MED7 and DRIP36/MED4, were not de-
tected in our mediator complex. However, MED10, MED21,
and MED31, which were found in the keratinocyte mediator
complex, could potentially substitute for these two subunits
in the middle module. The subunit MED21, when silenced,
promoted keratinocyte proliferation and the expression
of cyclin D1. It also blocked calcium-induced differentiation
and calcium-induced membrane localization of the
E-cadherin–b-catenin complex. These results are comparable
with those seen with the silencing of MED1. However,
MED21 silencing did not block 1,25(OH)2D3 induction of
24OHase unlike the effect of MED1 silencing. Neither MED1
nor MED21 silencing blocked 1,25(OH)2D3 induction of
CAMP or PADI1, consistent with the role of the mediator
complex in the early, but not the terminal events in VDR
regulated keratinocyte differentiation. In contrast reducing
the expression of MED10 inhibited proliferation and pro-
moted both 24OHase and CAMP induction by 1,25(OH)2D3.
The repressor function of MED10 in transcription was also
previously reported in yeast (Tabtiang and Herskowitz, 1998).
However, the effects of MED10 silencing on calcium
induction of the differentiation markers were comparable, if
not as extensive as those seen, with MED21 and MED1
silencing. Silencing MED31 had comparable effects with
MED10 on calcium induced differentiation markers, but its
impact on keratinocyte proliferation and 1,25(OH)2D3
induction of 24OHase and CAMP was negligible. These
results indicate that the mediator complex in keratinocytes
contains functionally distinct subunits to facilitate and/or
repress VDR function.
Our results further indicate that MED21/MED1 are
involved in 1,25(OH)2D3/VDR regulation of Wnt signaling.
MED21/MED1 in association with VDR may compete
with LEF/TCF for b-catenin and, hence, limit the induction
of Wnt target genes involved with proliferation such as cyclin
D1. However, other Wnt target genes involved with terminal
differentiation such as PADI1, which are activated by
1,25(OH)2D3/VDR, were not involved in proliferation. Thus,
VDR can either repress or activate Wnt target gene expression
depending on the gene, and for these genes mediator subunits
may be differentially involved in their repression and
activation.
Part of the mechanism by which VDR and mediator
subunits regulate Wnt signaling could also be attributed to the
ability of 1,25(OH)2D3 /VDR to regulate the distribution of
b-catenin within the cell by facilitating calcium-induced
formation of the E-cadherin–b-catenin complex in the
membrane. Formation of this complex is required for
calcium-induced differentiation of the keratinocyte (Xie and
Bikle, 2007). Silencing MED1 and MED21, as well as VDR
prevents the calcium-induced formation of this complex in the
membrane. Recently we have shown that the CaR is required
for the formation of the E-cadherin–b-catenin complex. The
CaR forms a complex with the scaffolding protein filamin A
(paper submitted) and activates Rho signaling (Tu et al., 2008),
which would promote E-cadherin translocation, accompanied
by cytoskeleton rearrangement. It also stimulates Fyn/Src
kinases, which then phosphorylate b-, g-,and p120-catenin,
promoting their binding to E-cadherin at the cell membrane
(Tu et al., 2008). In earlier studies we had shown that CaR in
keratinocytes was induced by 1,25(OH)2D3 (Ratnam et al.,
1999). In this study we show that silencing MED1, as well as
VDR suppresses the expression of CaR and its translocation
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to the membrane after calcium stimulation. This suggests
a mechanism, outlined above, by which VDR/Mediator is
required for E-cadherin–b-catenin complex formation, so
is necessary for the differentiation process.
Previous studies showed that VDR binds to the DRIP
Mediator complex in the presence of 1,25(OH)2D3 (Oda
et al., 2003). However, our current results suggest that MED1
may be involved in 1,25(OH)2D3-independent repression by
VDR of the cyclin D1 and Gli 1 genes. Such 1,25(OH)2
D3-independent actions of VDR have previously been
reported in keratinocyte culture systems, in which VDR
forms transcriptional regulatory complexes with retinoid X
receptor (RXR) in the absence of 1,25(OH)2D3 (Ellison et al.,
2007) and stimulates the expression of various differentiation
markers (Hawker et al., 2007). Keratinocyte specific mod-
ulatory proteins, signaling pathways or alternative ligands
may potentially be involved in the function of VDR-mediator
in the absence 1,25(OH)2D3.
Our previous studies (Oda et al., 2003) did not exclude the
presence of an alternative ligands in keratinocytes because
the mediator complex was isolated from dialyzed nuclear
extracts from which small molecule ligands were removed,
then 1,25(OH)2D3 was externally added to GST-VDR
affinity beads. Recently, a potential alternative ligand,
20-hydroxyvitamin D3, was reported to activate VDR and
induce keratinocyte differentiation (Zbytek et al., 2008). This
potential ligand may be produced from vitamin D3 using
cytochrome P450scc, which is present in keratinocytes
(Tuckey et al., 2008). It is also possible that MED1 alters
the expression of genes like cyclin D1 and Gli 1 through
other transcription factors than VDR, factors that would not
require 1,25(OH)2D3 as ligand.
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Figure 5. The silencing of MED1 and MED21 results in defects in keratinocyte differentiation. Keratinocytes were transfected with small interfering RNA
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measurements (most SD are too small to visualize on the graph). The experiments were repeated twice to confirm their reproducibility.
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Our results show that both MED1 and MED21 have critical
roles for both in proliferation and some aspects of differentia-
tion. These results do not entirely support our initial model
(Oda et al., 2003), wherein mediator was isolated from
proliferating keratinocytes, whereas other coactivator SRCs
were found from differentiated keratinocytes. In addition, our
preliminary results using GST-VDR affinity beads showed
DRIP complex was found in partially differentiated keratino-
cytes too (data not shown). We now modify our previous
model by proposing that mediator regulate cell proliferation,
that both mediator and SRCs are used during the earlier and
mid stages of differentiation, but that terminal differentiation
processes including barrier formation (Oda et al., 2009) and
innate immunity (Schauber et al., 2008) are dependent on
SRCs, but not MED1. However, LOR and FLG, so called
‘‘late’’ differentiation markers, require both coactivators
perhaps because these genes are initially induced in less
differentiated keratinocytes than the genes involved in
permeability barrier or innate immunity.
MED1 is known to bind to other nuclear receptors, such as
PPAR, which have also been found to have a role in
keratinocyte differentiation (Hanley et al., 1998, 2000;
Schmuth et al., 2004). Therefore, the effect of MED1 may
not be specific for VDR. However, phenotypes resulting from
MED1 silencing are similar to those caused by the loss of
VDR, suggesting that MED1 and MED21 work primarily
through VDR to regulate proliferation and differentiation in
keratinocytes.
In this study, we characterized the mediator complex
from primary keratinocytes. The newly described subunit
MED21 and core subunit MED1 were found to facilitate
VDR function and to regulate keratinocyte proliferation
and differentiation. In examining genes that are regulated
by b-catenin and VDR, we found that MED21/MED1
facilitates some, but not all actions of VDR in their
transcription. These studies further increase our understand-
ing of the biological function of the transcriptional coacti-
vator complex mediator in normal skin and may further
increase our understanding of the aberrant VDR and/or Wnt
signaling in hyperproliferative skin tumors, such as tricho-
folliculomas (hair follicle tumors), basal, and squamous cell
carcinomas.
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MATERIALS AND METHODS
Cell culture
Normal epidermal keratinocytes were isolated from neonatal-human
foreskin and grown in serum-free keratinocyte growth medium
(Cascade Biologics, Portland OR) as previously described (Gibson
et al., 1996). Second passage keratinocytes were cultured with
keratinocyte growth medium containing 0.03mM calcium to
maintain them in a proliferating stage. To induce keratinocyte
adhesion, cells were treated with the same medium containing high
calcium (1.2mM) for 5minutes. To induce differentiation, cells were
switched to high-calcium medium and maintained for 3–7 days. The
study was conducted according to Declaration of Helsinki Principles.
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Figure 6. The function of MED1 and MED21 in calcium-induced E-cadherin translocation. Keratinocytes were transfected with small interfering RNA
(siRNA) to block expression of vitamin D receptor (VDR) or mediator subunits, and treated with calcium for 5minutes to initiate keratinocyte adhesion.
Translocation of E-cadherin (green) and b-catenin (red) to the membrane was visualized by immunofluorescence (green and red images were superimposed,
so that sites of overlap are visualized as yellow) (a). Bars ¼20 mm. Calcium-induced E-cadherin translocation to the plasma membrane (b, western analysis,
upper lanes) compared with that in total lysates (b, lower lanes). The mRNA expression of calcium-sensing receptor (CaR; c, left panel) and the calcium-induced
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Purification of VDR binding proteins from keratinocytes
VDR binding proteins were purified using GST-VDR affinity beads as
described previously (Oda et al., 2003). Briefly, nuclear extracts were
prepared from proliferating keratinocytes as described and incubated
with GST-VDR (LBD) affinity beads in the presence of 1 10–6 M
1,25(OH)2D3. Bound proteins were eluted with 0.2% sarkosyl, separated
by SDS–PAGE, and visualized by silver staining (Oda et al., 2003).
Protein identification by MS
Protein bands were excised from the SDS gel. Minced gel pieces
were reduced using dithiothreitol (DTT). Free cysteines were
alkylated using iodoacetamide, and the proteins were digested using
trypsin (12.5 ng ml1 in 25mM ammonium bicarbonate) at 37C
overnight. Peptides were extracted with 50% acetonitrile, 2% formic
acid. Extracted peptides were vacuum centrifuged to dryness,
resuspended in 0.1% formic acid and analyzed by LC-MSMS using
a QSTAR Pulsar (AB Sciex, Foster City, CA). A Pepmap column
(75mm internal diameter 150mm, Dionex, Sunnyvale, CA) was
used for HPLC separation, using a gradient of 0–40% acetonitrile or
0.1% formic acid over 30minutes. When a peptide was observed
above minimum threshold intensity in the mass spectrum, it was
automatically selected for fragmentation by collision-induced
dissociation. Fragmentation spectra were analyzed against the
Uniprot protein database (21 April 2006) using Protein Prospector
(Chalkley et al., 2005) (http://prospector.ucsf.edu). Only proteins
identified by two or more different peptides were reported. Bait
protein, several bacterial proteins, and keratin peptides were also
identified in addition to the proteins reported in Table 1.
siRNA silencing and measurement of mRNA expression
A pool of four siRNA duplexes with UU overhangs and a 50 phosphate
on the antisense strand specific for human MED1 (SMART pool PLUS M-
004267-00 50-GGTCTGATTTGGTTAAGAA-30, 50-GTTCAGAGATCA
TAGGAAT-30, 50-TAAATAGGGTTCAGAGATC-30, 50-CAAGCTGGGT
GAATTAGAA-30), human VDR (siGENOME duplexes MQ-003448-00-
0005, 50-TGAAGAAGCTGAACTTGCA-30, 50-GCAACCAAGACTA
CAAGTA-30, 50-TCAATGCTATGACCTGTGA-30, 50-CCATTGAGGT
CATCATGTT-30), human MED10L-014834-01-0005, human MED21
(SURB7) L-016221-00-0005, and human MED31L-027282-00-0005
were designed and synthesized by Dharmacon Research (Lafayette,
CO) using SMART selection and SMART pooling technologies. As a
control a nonspecific SMARTpool (D-0012206-13-05) were used.
Keratinocytes (12-well plate) were transfected with 20nM siRNA
oligonucleotides using 2ml siLentFect (Bio-Rad, Hercules, CA) in
keratinocyte growth media containing 0.03mM or 1.2mM calcium. The
cells were transfected twice (24hours apart) to maximize the silencing
effect. The cells were then treated with either EtOH or 1 10–8–1 107
M 1,25(OH)2D3 overnight. To maximize their effects on 24OHase, cells
were treated with a lower concentration of 1,25(OH)2D3 (1 109M),
which causes less induction of 24OHase but increases sensitivity to
inhibition of 1,25(OH)2D3 induced transactivation.
QPCR analysis
Total RNA was isolated from keratinocytes using RNeasy RNA
purification kit (Qiagen, Valencia, CA), and cDNA was prepared
using reverse transcription kit (Applied Biosystems, Foster City, CA).
The mRNA expression of human 24OHase, CAMP, Cyclin D1,
Gli 1, K15, PADI1, K1, K10, transglutaminase, involucrin, LOR,
FLG was measured by QPCR using SYBR green master mix
(Applied Biosystems) in real-time PCR instruments 7900 HT or
7300 (Applied Biosystems). Relative expression of these genes
compared with mitochondrial ribosomal protein L19 was calculated.
Primers for QPCR analysis were designed using Primer Express
(Applied Biosystem) to span the exon and intron boundaries. Primer
sets were verified by drawing dissociation curves. Primer sequences
for QPCR are available in supplements. These experiments were
repeated using two or three different batches of primary keratino-
cytes to confirm reproducibility.
Proliferation
Keratinocyte proliferation was evaluated by measurement of cell
numbers using Cell Proliferation kit II (XTT; Roche Applied Science,
Indianapolis, IN) according to the manufacturer’s instruction.
Proliferation was also assessed by the measurement of DNA synthesis.
Keratinocytes were labeled with BrdU for 6hours. The incorporated
BrdU was detected by a BrdU kit (Zymed, Invitrogen, Carlsbad, CA)
according to the manufacturer’s instructions. Digital images of three
representative fields per experimental condition were acquired
and quantified using a computer-assisted program (BIOQUANT,
Nashville, TN). Percentages of BrdU-positive cells per total cells were
calculated. To normalize the data in different experiment, the
percentage of BrdU-positive cells to that in the sicontrol group was
further calculated. Student’s t-test was used for statistic analysis.
Immunofluorescence
The localization of E-cadherin and b-catenin was examined as
described (Tu et al., 2008). Briefly, keratinocytes cultured on coverslips
were transfected with siRNA in low calcium medium (0.03mM) for 3
days. Cells were treated with high calcium (1.2mM) medium for
5minutes, then fixed and permeabilized. After blocking, cells were
incubated with 10mgml1 of antibodies against E-cadherin (Santa Cruz
Biotechnology, Santa Cruz, CA) and b-catenin (Santa Cruz) and
subsequently incubated with fluorescein- or Texas Red-conjugated
secondary antibody (20mgml1, Molecular Probes, Invitrogen).
Cell lysate preparation
Total cell lysates and membrane proteins were prepared from
keratinocytes as described (Tu et al., 2008). Briefly, keratinocytes
were lysed in Nonidet P-40 lysis buffer (0.5%; total lysates).
Membrane lysates and nuclear extracts were prepared using the
Mem-PER Eukaryotic Membrane Protein Extraction reagent Kit
(Pierce Biotechnology, Rockford, IL) and Nuclear Extraction Kit
(Pierce Biotechnology) according to the manufacturer’s protocols.
Protein analysis by western blot
The protein expression of VDR, MED1, and E-cadherin was detected
by western analysis as described (Oda et al., 2003; Tu et al., 2008).
Briefly, 20mg of total RIPA lysates (for VDR) or nuclear extracts (for
MED1) or total NP-40 lysates (total protein for E-cadherin) or
membrane lysates (for E-cadherin) were electrophoresed through
SDS–PAGE and electroblotted onto a PVDF membrane. After
blocking, the blots were incubated with antibodies raised against
VDR (Santa Cruz D-6; 1:200), or MED1 (Santa Cruz TRAP220 C-19;
1:1000) or E-cadherin (Santa Cruz H-108; 1:1000) or CaR (ADD;
1:500). Subsequently, the blot was incubated with secondary
antibody conjugated with HRP (GE Healthcare/Amersham,
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Piscataway, NJ), and bound antibody was visualized using a chemilu-
minescence system (SuperSignal ULTRA, Pierce Biotechnology).
The Committee for Human Research (IRB) of the University of
California, San Francisco and the Veterans Affairs Medical Center
approved all described studies with the human keratinocytes.
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